YBX3 and nonpapillary renal cell carcinoma: In order to clarify the effect of YBX3 on the progression of ccRCC in vitro, siRNAs were first used to knock down YBX3 in the ccRCC cell line A498, which highly expresses YBX3, and the efficiency of the knockdown was confirmed by qRT-PCR and western blot analyses.